With favorable radiation dosimetry, compared to 68Ga-PSMA-11 (0.0088 mSv/MBq vs. 0.022 mSv/MBq), 99mTc-MIP-1404 has shown imrpoved efficacy in patients with intermediate-to-high-risk PCa 74, 78. The gene discussed is FOLH1; the disease is posterior cortical atrophy.